✦ LIBER ✦

393 A phase II study of OSI-774 given in combination with carboplatin in patients with recurrent ovarian cancer (NCIC IND.149)

✍ Scribed by H. Hirte; K. Swenerton; A. Oza; S. Ellard; M. Plante; R. Grimshaw; M. Carey; L. Seymour; B. Fisher; W. Walsh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib (OSI-774)

✍ H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

159 Phase II study of OSI-774 given in c

✍ H. Hirte; A. Oza; P. Hoskins; S. Ellard; R. Grimshaw; J. Dubuc-Lissoir; I. Kerr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II study of carboplatin and erloti

✍ J. F. de Groot; M. R. Gilbert; K. Aldape; K. R. Hess; T. A. Hanna; S. Ictech; M. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 255 KB

Whole-body hyperthermia (WBH) in combina

✍ Akin Atmaca; Salah-Eddin Al-Batran; Antje Neumann; Yvonne Kolassa; Dirk Jäger; A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A Phase I/II Study of Topotecan in Combi

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Phase II study of erlotinib (OSI-774) in

✍ Townsley, C A; Major, P; Siu, L L; Dancey, J; Chen, E; Pond, G R; Nicklee, T; Ho 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 221 KB